Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06OBP
|
|||
Former ID |
DNC002598
|
|||
Drug Name |
1-Hydroxy-2-Amino-3-Cyclohexylpropane
|
|||
Synonyms |
(S)-2-Amino-3-cyclohexylpropan-1-ol; 131288-67-0; (S)-2-Amino-3-cyclohexyl-propan-1-ol; 1-Hydroxy-2-Amino-3-Cyclohexylpropane; CHEMBL1231778; (S)-2-AMINO-3-CYCLOHEXYL-1-PROPANOL; (2S)-2-Amino-3-Cyclohexylpropan-1-Ol Hydrochloride; 205445-49-4; (2S)-2-amino-3-cyclohexylpropan-1-ol; AC1L9GJG; AC1Q4UB7; SCHEMBL82667; S-2-Amino-3-cyclohexylpropanol; KS-00000LNV; QWDRYURVUDZKSG-VIFPVBQESA-N; MolPort-000-000-987; ZINC154757; ZX-CM013052; (S)-cyclohexylalaninol, AldrichCPR; BDBM50367060; FCH835925; AKOS022180681; MB00862; DB04387
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C9H19NO
|
|||
Canonical SMILES |
C1CCC(CC1)CC(CO)N
|
|||
InChI |
1S/C9H19NO/c10-9(7-11)6-8-4-2-1-3-5-8/h8-9,11H,1-7,10H2/t9-/m0/s1
|
|||
InChIKey |
QWDRYURVUDZKSG-VIFPVBQESA-N
|
|||
CAS Number |
CAS 205445-49-4
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
7886584, 10299546, 36887547, 46506482, 50486690, 81052035, 87358097, 104247959, 104632416, 117518389, 118867708, 129083722, 135371311, 135829048, 140264752, 160846162, 160967414, 162184747, 170538932, 172659045, 186007123, 215780084, 223523581, 223755337, 226461415, 249855584, 250228133, 251867048, 252079789
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Angiotensinogenase renin (REN) | Target Info | Inhibitor | [1] |
KEGG Pathway | Renin-angiotensin system | |||
Pathwhiz Pathway | Angiotensin Metabolism | |||
Reactome | Metabolism of Angiotensinogen to Angiotensins | |||
WikiPathways | ACE Inhibitor Pathway | |||
Metabolism of Angiotensinogen to Angiotensins |
References | Top | |||
---|---|---|---|---|
REF 1 | How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.